Related Experiment Video
Updated: Jun 27, 2025

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
Lipid-Derived Biomarkers as Therapeutic Targets for Chronic Coronary Syndrome and Ischemic Stroke: An Updated
Thomas Gabriel Schreiner1,2,3, Bogdan Emilian Ignat1,4, Cristina Grosu1,4
1Department of Medical Specialties III, Faculty of Medicine, University of Medicine and Pharmacy "Grigore T. Popa", 700115 Iasi, Romania.
This review explores how lipid biomarkers, like cholesterol and oxylipins, are crucial in understanding and treating heart (chronic coronary syndrome) and brain (ischemic stroke) conditions. Early detection and targeted therapies using these markers can improve patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Neurology
- Biomarker Research
Background:
- Rising global incidence of cardiac and cerebrovascular diseases, particularly chronic coronary syndrome and ischemic stroke.
- The heart-brain axis involves shared pathophysiological mechanisms in cardiac and cerebral ischemia.
- Need for personalized medical treatments focusing on prevention and early intervention of risk factors.
Purpose of the Study:
- To provide an updated overview of lipid-derived biomarkers in chronic coronary syndrome and ischemic stroke.
- To elucidate the role of biomarkers like low-density lipoprotein cholesterol, oxylipins, and apolipoproteins in disease pathogenesis.
- To present current and experimental targeted therapies based on these lipid biomarkers.
Main Methods:
- Narrative review of epidemiological data.
- Analysis of the role of various lipid-derived biomarkers in the pathogenesis of chronic coronary syndrome and ischemic stroke.
- Review of existing and emerging therapeutic strategies targeting lipid biomarkers.
Main Results:
- Significant epidemiological burden of chronic coronary syndrome and ischemic stroke highlighted.
- Detailed listing of key lipid-derived biomarkers and their involvement in disease development.
- Presentation of targeted therapies, both current and experimental, linked to these biomarkers.
Conclusions:
- Lipid-derived biomarkers play a critical role in the pathophysiology of chronic coronary syndrome and ischemic stroke.
- Understanding these biomarkers is essential for developing targeted and personalized treatment strategies.
- This review offers novel insights into therapeutic interventions for these prevalent cardiovascular and cerebrovascular conditions.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin,...
Inflammation

